Compare PRTH & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRTH | TECX |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | 1019 | 51 |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.1M | 393.0M |
| IPO Year | N/A | N/A |
| Metric | PRTH | TECX |
|---|---|---|
| Price | $4.80 | $30.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $8.33 | ★ $75.25 |
| AVG Volume (30 Days) | ★ 275.8K | 261.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.76 | N/A |
| Revenue Next Year | $6.79 | N/A |
| P/E Ratio | $10.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.44 | $13.70 |
| 52 Week High | $8.89 | $35.99 |
| Indicator | PRTH | TECX |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 55.13 |
| Support Level | $4.44 | $18.52 |
| Resistance Level | $6.01 | $35.99 |
| Average True Range (ATR) | 0.18 | 1.73 |
| MACD | -0.01 | -0.45 |
| Stochastic Oscillator | 33.85 | 37.06 |
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium business enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments, and Enterprise Payments. SMB Payments segment which generates the majority of revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging Priority's proprietary software platform, distributed through ISO; the B2B Payments segment provides AP automation solutions to corporations, software partners, & industry FIs: and Enterprise Payments segment provides embedded payment & treasury solutions to enterprise customers to modernize legacy platforms & accelerate software partners' strategies to monetize payments.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.